A Review Article on Innovative Strategies for Thalassemia

Abstract

Thalassemia, a genetic blood disorder characterized by abnormal hemoglobin synthesis, poses a significant global health challenge. With a higher prevalence in the Mediterranean, Middle East, Asia, and parts of Africa, thalassemia has profound implications for affected individuals and healthcare systems. Public health initiatives, including awareness campaigns, genetic screening programs, and advancements in treatment, play a crucial role in mitigating the impact of this hereditary condition. However, economic disparities, inadequate healthcare infrastructure, and cultural barriers hinder effective management and prevention strategies. This study aims to explore the current state of thalassemia management, highlighting the obstacles to optimal care while recommending  evidence-based  public  health  strategies  to  enhance  treatment  outcomes  and prevention  measures.Public  health  initiatives  addressing  thalassemia  encompass  a  range  of strategies, including education campaigns, genetic screening, and improved access to treatment. Educational  programs  inform  communities  and  healthcare  professionals  about  the  disorder, inheritance patterns, and the importance of genetic counseling. Additionally, specialized treatment centers and research collaborations enhance the accessibility and quality of care for thalassemia patients. Studies in various regions, including Cambodia, Pakistan, and other high-prevalence areas, indicate that while awareness and screening acceptance are increasing, gaps remain in healthcare  accessibilityand  policy  implementation.  Despite  advancements  in  thalassemia management, persistent challenges necessitate morecomprehensive and inclusive public health strategies.  Addressing  socioeconomic  disparities,  improving  healthcare  infrastructure,  and fostering  culturally  sensitive  genetic  counseling  are  essential  for  effective prevention  and treatment.